Profile
Zvi Ioav Cabantchik is the founder of Aferrix Ltd.
(founded in 2002) and holds the title of Director.
He is currently a Professor at The Hebrew University of Jerusalem since 1979.
His former position was as Principal at Scots College Charitable Trust from 2006 to 2009.
Dr. Cabantchik's education includes an undergraduate degree from The Hebrew University of Jerusalem in 1965, a graduate degree from The Hebrew University of Jerusalem in 1966, and a doctorate degree from the University of Rochester Medical Center in 1974.
Zvi Ioav Cabantchik active positions
Companies | Position | Start |
---|---|---|
Aferrix Ltd.
Aferrix Ltd. Medical SpecialtiesHealth Technology Aferrix Ltd. develops tools for early diagnosis and monitoring of toxic iron in the serum. The firm offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (thalassemia, hemochromatosis, myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. Its products include FeROS eLPI and FeROS LPI. The company was founded by Zvi Ioav Cabantchik and Alexander Silberman on February 10, 2002 and is headquartered in Tel Aviv, Israel. | Founder | 10/02/2002 |
The Hebrew University of Jerusalem | Corporate Officer/Principal | 01/01/1979 |
Former positions of Zvi Ioav Cabantchik
Companies | Position | End |
---|---|---|
Scots College Charitable Trust | Corporate Officer/Principal | 01/01/2009 |
Training of Zvi Ioav Cabantchik
The Hebrew University of Jerusalem | Undergraduate Degree |
University of Rochester Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Aferrix Ltd.
Aferrix Ltd. Medical SpecialtiesHealth Technology Aferrix Ltd. develops tools for early diagnosis and monitoring of toxic iron in the serum. The firm offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (thalassemia, hemochromatosis, myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. Its products include FeROS eLPI and FeROS LPI. The company was founded by Zvi Ioav Cabantchik and Alexander Silberman on February 10, 2002 and is headquartered in Tel Aviv, Israel. | Health Technology |
Scots College Charitable Trust |
- Stock Market
- Insiders
- Zvi Ioav Cabantchik